3Goshima S, Kanematsu M,Kondo H, et al. Hepatic hemangio ma: correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients[J]. European Journal of Radiology, 2009,70 (2): 325-330.
4Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma [ J ]. A JR Am J Roentgenol,1995,165(6) :1427-1431.
5Fowler K J, Brown J J, Narra VR. Magnetic resonance imaging of focal liver lesions : approach to imaging diagnosis [ J 1. Hepatology, 2011,54(6) :2227-2237.
6Sempoux C, Jibara G, Ward SC, et al. Intrahepatic cholangiocarcinoma: new insights in pathology [ J ]. Semin Liver Dis,2011,31 ( 1 ) :49-60.
7Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States [ J ] Hepatology,2001,33 ( 6 ) : 1353-1357.
8Takayama T, Makuuchi M, Kojiro M, et al. Early hepatocellular carcinoma : pathology, imaging, and therapy [ J ]. Ann Surg Oncol, 2008,15 (4) :972-978.
9Yamashita Y, Ogata I, Urata J, et al. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings [ J ]. Radiology, 1997,203( 1 ) :121-125.
10Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, PDG PET, and/or FDG PET/CT:a meta-analysis of prospective studies including patients who have not previously undergone treatment [ J ]. Radiology, 2010,257 (3) :674-684.
